• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

39.9726 USD 0.2374 0.59%

As of 15:19:27 ET on 04/24/2014.

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 40.5300 High - Low: 40.8600 - 39.2100 Primary Exchange: NYSE Arca
Volume: 67,223 52-Week Range: 27.5301 - 46.9836 Beta vs DZOTR: 1.0019

ETF Chart for PBE

No chart data available.
  • PBE:US 39.9726
  • 1D
  • 1M
  • 1Y
40.2100
Interactive PBE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2014-04-23) 40.1984
Assets (M) (on 2014-03-31) 408.4640
Shares out (M) 9.00
Market Cap (M) 361.53
% Premium 0.03
Average 52-Week % Premium 0.0671
Fund Leveraged N

Dividends for PBE

Dividend Type Discontinued
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for PBE

1-Month -7.20% 1-Year +41.48%
3-Month -5.23% 3-Year +21.04%
Year To Date +8.53% 5-Year +27.15%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 04/23/2014
Name Position Value % of Total
Sigma-Aldrich Corp 214,443 20,119,042 5.559%
Amgen Inc 163,254 18,499,127 5.112%
Regeneron Pharmaceuticals Inc 60,899 18,457,269 5.100%
Biogen Idec Inc 59,434 18,231,380 5.038%
Illumina Inc 118,063 18,145,102 5.014%
Gilead Sciences Inc 244,550 18,062,463 4.991%
Alexion Pharmaceuticals Inc 114,523 17,433,836 4.817%
Pharmacyclics Inc 146,023 13,669,213 3.777%
Myriad Genetics Inc 304,978 12,101,527 3.344%
Emergent Biosolutions Inc 446,392 11,829,388 3.269%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil